Italia markets close in 3 hours 28 minutes

SWTX Dec 2024 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,36000,0000 (0,00%)
In data: 03:41PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,3600
Aperto4,3600
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio35,00
Scadenza2024-12-20
Min-Max giorno4,3600 - 4,3600
Contratto - Min-MaxN/D
Volume20
Open Interest70
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (